The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies.

IF 1.5 Q3 HEALTH CARE SCIENCES & SERVICES
Timothy H Barker, Sabira Hasanoff, Edoardo Aromataris, Jennifer Stone, Jo Leonardi-Bee, Kim Sears, Nahal Habibi, Miloslav Klugar, Catalin Tufanaru, Sandeep Moola, Xian-Liang Liu, Zachary Munn
{"title":"The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies.","authors":"Timothy H Barker, Sabira Hasanoff, Edoardo Aromataris, Jennifer Stone, Jo Leonardi-Bee, Kim Sears, Nahal Habibi, Miloslav Klugar, Catalin Tufanaru, Sandeep Moola, Xian-Liang Liu, Zachary Munn","doi":"10.11124/JBIES-24-00103","DOIUrl":null,"url":null,"abstract":"<p><p>Cohort studies are a robust analytical observational study design that explore the difference between two different cohorts on an outcome, differentiated by their exposure status. Despite being observational in nature, they are often included in systematic reviews of effectiveness, particularly when randomized controlled trials are limited or not feasible. Like all studies included in a systematic review, cohort studies must undergo a critical appraisal process to assess the extent to which a study has considered potential bias in its design, conduct, or analysis. Critical appraisal tools facilitate this evaluation. This paper introduces the revised critical appraisal tool for cohort studies, completed by the JBI Effectiveness Methodology Group (EMG), who are currently revising the suite of JBI critical appraisal tools for quantitative study designs. The revised tool responds to updates in methodological guidance from the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group and reporting guidance from PRISMA 2020, providing a robust framework for evaluating risk of bias in a cohort study. Transparent and rigorous assessment using this tool will assist reviewers in understanding the validity and relevance of the results and conclusions drawn from a systematic review that includes cohort studies. This may contribute to better evidence-based decision-making in health care. This paper discusses the key changes made to the tool, justifications for these changes, and provides practical guidance on how this tool should be interpreted and applied by systematic reviewers.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBI evidence synthesis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11124/JBIES-24-00103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Cohort studies are a robust analytical observational study design that explore the difference between two different cohorts on an outcome, differentiated by their exposure status. Despite being observational in nature, they are often included in systematic reviews of effectiveness, particularly when randomized controlled trials are limited or not feasible. Like all studies included in a systematic review, cohort studies must undergo a critical appraisal process to assess the extent to which a study has considered potential bias in its design, conduct, or analysis. Critical appraisal tools facilitate this evaluation. This paper introduces the revised critical appraisal tool for cohort studies, completed by the JBI Effectiveness Methodology Group (EMG), who are currently revising the suite of JBI critical appraisal tools for quantitative study designs. The revised tool responds to updates in methodological guidance from the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group and reporting guidance from PRISMA 2020, providing a robust framework for evaluating risk of bias in a cohort study. Transparent and rigorous assessment using this tool will assist reviewers in understanding the validity and relevance of the results and conclusions drawn from a systematic review that includes cohort studies. This may contribute to better evidence-based decision-making in health care. This paper discusses the key changes made to the tool, justifications for these changes, and provides practical guidance on how this tool should be interpreted and applied by systematic reviewers.

用于评估队列研究偏倚风险的 JBI 关键评估工具修订版。
队列研究是一种稳健的分析性观察研究设计,用于探讨两个不同队列之间在某一结果上的差异,并根据其暴露状态加以区分。尽管是观察性研究,但它们经常被纳入有效性系统综述,尤其是在随机对照试验有限或不可行的情况下。与所有纳入系统综述的研究一样,队列研究必须经过严格的评估过程,以评估研究在设计、实施或分析中考虑潜在偏倚的程度。批判性评价工具有助于进行这种评估。本文介绍了由JBI有效性方法学小组(EMG)完成的队列研究关键评价工具修订版,该小组目前正在修订JBI定量研究设计关键评价工具套件。修订后的工具响应了推荐、评估、发展和评价分级(GRADE)工作组更新的方法学指南和 PRISMA 2020 的报告指南,为评估队列研究的偏倚风险提供了一个稳健的框架。使用该工具进行透明、严格的评估将有助于审稿人了解包含队列研究的系统性综述中得出的结果和结论的有效性和相关性。这将有助于在医疗保健领域做出更好的循证决策。本文讨论了对该工具所做的主要改动、这些改动的理由,并就系统综述者如何解释和应用该工具提供了实用指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JBI evidence synthesis
JBI evidence synthesis Nursing-Nursing (all)
CiteScore
4.50
自引率
3.70%
发文量
218
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信